Gastric Balloon Market size is expected to be valuated at USD 297.8 Million by 2035; Growing Focus on Non-Surgical Weight Loss Solutions to Accelerate Market Growth

Published Date: October 2025

A gastric balloon is a soft inflatable balloon that is inserted in the stomach in order to make the patients manage the amounts of food to eat and also, lose weight without undergoing an operation. This is a simple, temporary treatment that is becoming popular in the world as the incidences of obesity continue to rise. The progress to minimally invasive weight loss technologies, improvements in gadget safety, and increased awareness of health-related risks of obesity are the drivers of market growth. Efforts in medical favorable guidelines and increase in healthcare expenditure are other positive contributors to adoption.

Segmentation Analysis:

By Device

Single-balloon Systems, Dual-balloon Systems, Adjustable/Volume-Controlled Balloons, Capsule-based Balloons, and Others

By Mode of Administration

Endoscopic Insertion, Swallowable Capsule, and Surgical/Minimally Invasive Laparoscopic

By Filling Material

Saline-Filled Balloons, Gas-Filled Balloons, and Hybrid (Liquid Gas filled)

By Duration

Short-term (< 6 months), Medium-term (6–12 months), and Long-term (>12 months)

By End User

Hospitals, Ambulatory Surgical Centers (ASCs), Bariatric & Weight-Loss Clinics, Specialized Gastroenterology Centers, and Others

Report Highlights:

  • Gastric balloon market size is valuated at USD 132.5 Million in 2025.
  • Target market size is estimated to be valuated at USD 297.8 Million by 2035 and at a CAGR of 10.3%.
  • In terms of devices, single-balloon systems holds the largest gastric balloon market share.
  • Endoscopic insertion are most dominant when it comes to mode of administration for the gastric balloon market growth.
  • In terms of filling material, saline-filled balloons are the most dominant for the gastric balloon market size.
  • In terms of duration, short term which is less than or up to 6 months is most common for the gastric balloon market.
  • Hospitals are the most dominant when it comes to end user for the gastric balloon market share.
  • North America is dominating region in the gastric balloon market size.
  • The Europe region is seeing the fastest growth in the gastric balloon market share.

Market Dynamics:

Growing Factor

Challenge Factor

Market Trend

Growing Awareness of Obesity Related Health Risks

High Treatment Costs

Development of Swallowable and Adjustable Gastric Balloons

Key Highlights:

  • In July 2025, ReShape Lifesciences plans to grant a U.S. patent for their novel intragastric balloon device in. The invention proposes a swallowable and degradable balloon with a self-sealing fill valve and natural excretion capabilities, expanding the company's intellectual property. This breakthrough increases ReShape's competitiveness in non-surgical weight-loss methods by offering it patent protection until at least 2031.

Report Analysis:

Intra-gastric Balloon with Lifestyle Modification:

Intra-gastric balloon therapy together with structured lifestyle-modification is a good non-surgical option in weight management. This is a quick weight loss that is backed by not only balloon placement but also a sustainable lifestyle change with exercise and diet programs. This method is effective as it aims at both physiological and behavioral treatment of obesity and thus the patient is able to sustain their results even after balloon removal. These integrated strategies are becoming the topic of attention as the safe and holistic solutions in the bariatric device market.

Acute Pancreatitis as a late Complication of Intra-gastric Balloon Insertion:

Although the practicality of intra-gastric balloons is well-known in terms of harmlessness and effectiveness during weight loss, some uncommon complications can emerge later in the treatment, including acute pancreatitis. This situation may be caused by the pressure or migration produced by the balloons, and it is necessary to check it and conduct medical attention. Such risks have brought to light the essence of close patient monitoring and early detection as an indicator of treatment safety. Rising clinical interest in the management of complications is stimulating advances in balloon design and protocol.

Browse ∼70 market data tables and ∼65 figures through ∼230 slides and in-depth TOC on “Gastric Balloon Market Size, Share, By Device (Single-balloon Systems, Dual-balloon Systems, Adjustable/Volume-Controlled Balloons, Capsule-based Balloons, and Others), Mode of Administration (Endoscopic Insertion, Swallowable Capsule, and Surgical/Minimally Invasive Laparoscopic), Filling Material [(Saline-Filled Balloons, Gas-Filled Balloons, and Hybrid (Liquid Gas filled)], Duration [Short-term (<6 months), Medium-term (6–12 months), Long-term and (12> months), End User (Hospitals, Ambulatory Surgical Centers, Bariatric & Weight-Loss Clinics, Specialized Gastroenterology Centers, and Others), and Region - Trends, Analysis, and Forecast till 2035”

Segmentation:

By Device:

  • Single-balloon Systems
  • Dual-balloon Systems
  • Adjustable/Volume-Controlled Balloons
  • Capsule-based Balloons
  • Others

By Mode of Administration:

  • Endoscopic Insertion
  • Swallowable Capsule
  • Surgical/Minimally Invasive Laparoscopic

By Filling Material:

  • Saline-Filled Balloons
  • Gas-Filled Balloons
  • Hybrid (Liquid Gas filled)

By Duration:

  • Short-term ( < 6 months)
  • Medium-term (6–12 months)
  • Long-term (12 > months)

By End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Bariatric & Weight-Loss Clinics
  • Specialized Gastroenterology Centers
  • Others

By Region:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Russia
    • Italy
    • Spain
    • Netherlands
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • Indonesia
    • Malaysia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • Israel
    • South Africa
    • Rest of Middle East & Africa

For more insights into the Gastric Balloon Market and its future trends, visit link below: https://www.prophecymarketinsights.com/market_insight/Global-Gastric-Balloon-Market-By-2749

Competitive Landscape of Gastric Balloon Market:

The key players operating the gastric balloon market include Allurion, Boston Scientific Corporation, ReShape Lifesciences, Inc., Spatz FGIA Inc., Medispar NV, Districlass Médical, Helioscopie, Suzhou Shenyun Medical Equipment Co., Ltd, Endalis, Bariatric Solutions GmbH, Signel Biomedical Private Limited, COUSIN SURGERY, Beijing ZKSK Technology Co.,Ltd., Torrance Bariatric Institute, and SILIMED INDUSTRIA DE IMPANTES LTDA.

Company Name

Boston Scientific Corporation

Headquarter

Massachusetts, U.S

CEO

Michael F. Mahoney

Employee Count

35,000 Employees

Buy Now
Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Custmoized Your Report
Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

Request for Discount
Reliability and Reputation
Reliability and ReputationReliability and Reputation
Reliability and ReputationReliability and Reputation
Reliability and ReputationReliability and Reputation
Reliability and ReputationReliability and Reputation
Trusted By

Created billion dollars of revenue impact with more than 200+ clients

View All Our Clients
Trusted by Our Top Clients